Filing Details

Accession Number:
0000908662-14-000088
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-26 16:06:51
Reporting Period:
2014-02-24
Filing Date:
2014-02-26
Accepted Time:
2014-02-26 16:06:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
907562 Dyax Corp DYAX Services-Commercial Physical & Biological Research (8731) 043053198
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1134365 V George Migausky C/O Dyax Corp.
55 Network Drive
Burlington MA 01803-2756
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-02-24 11,875 $10.37 71,350 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 30,000 Indirect By Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan. The sales were primarily intended to provide liquidity sufficient to cover tax obligations due in connection with the vesting of restricted stock.
  2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $10.07 to $10.52, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.
  3. Shares are held in trusts, of which Mr. Migausky is the trustee, for the benefit of each of Mr. Migausky's children. Mr. Migausky disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.